AmTrust's former exclusive distribution partner in the Italian medical malpractice market has dismissed a series of claims made by the insurer's CEO Barry Zyskind on its recent earnings call.
AmTrust's former exclusive distribution partner in the Italian medical malpractice market has dismissed a series of claims made by the insurer's CEO Barry Zyskind on its recent earnings call.